Learn more about whether Halozyme Therapeutics, Inc. or Relay Therapeutics, Inc. is a better investment based on AAII's A+ ...
Everyday Health on MSN
The osteoporosis post-fracture protocol: How to stop one break from becoming three
If you've already had one bone break from osteoporosis, you're at risk for another. Here's what you can do to prevent future ...
Orforglipron is the second daily weight-loss pill to hit the market. The first was the Wegovy pill, from Novo Nordisk, which ...
The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit ...
4don MSN
FDA approves new daily GLP-1 pill — what to know, including how they compare to Wegovy tablets
*Gulp* Much to the relief of the needle-shy, the FDA has just approved a second oral GLP-1 drug, following the release of the ...
On March 30, 2026, the FDA approved a high dose regimen for Spinraza (nusinersen) for the treatment of spinal muscular atrophy.
People on Foundayo, the new GLP-1 weight loss pill from Eli Lilly, tend to feel full faster, and may experience nausea, ...
Balding or hair thinning but don't know which treatment to choose? We spoke with dermatologists to find out which hair loss treatments actually work.
The daily pill called Foundayo got a fast track through the Food and Drug Administration. It will compete with the pill form ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results